BioCentury | Apr 22, 2020
Finance
April 21 Financial Quick Takes: ORIC’s IPO plans; plus venture rounds for Magpie, Cloudbreak, ReAlta, New Horizon, Zikani
...with Abraxane nab-paclitaxel in solid tumors (see “ORIC Raises $55M” ). Guangzhou’s Magpie raises $14M Magpie Pharmaceuticals Co. Ltd....
